BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lorenzini S, Andreone P. Stem cell therapy for human liver cirrhosis: a cautious analysis of the results. Stem Cells. 2007;25:2383-2384. [PMID: 17540855 DOI: 10.1634/stemcells.2007-0056] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Lorenzini S, Gitto S, Grandini E, Andreone P, Bernardi M. Stem cells for end stage liver disease: How far have we got? World J Gastroenterol 2008; 14(29): 4593-4599 [PMID: 18698672 DOI: 10.3748/wjg.14.4593] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
2 Wang J, Zong C, Shi D, Wang W, Shen D, Liu L, Tong X, Zheng Q, Gao C. Hepatogenic engineering from human bone marrow mesenchymal stem cells in porous polylactic glycolic acid scaffolds under perfusion culture. J Tissue Eng Regen Med 2012;6:29-39. [DOI: 10.1002/term.393] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
3 Wu K, Huang R, Wu H, Liu Y, Yang C, Cao S, Hou X, Chen B, DaI J, Wu C. Collagen-binding vascular endothelial growth factor attenuates CCl4-induced liver fibrosis in mice. Mol Med Rep. 2016;14:4680-4686. [PMID: 27748931 DOI: 10.3892/mmr.2016.5826] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
4 Singh G, Chanda A. Mechanical properties of whole-body soft human tissues: a review. Biomed Mater 2021;16. [PMID: 34587593 DOI: 10.1088/1748-605X/ac2b7a] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bressan E, Carraro A, Ferroni L, Gardin C, Sbricoli L, Guazzo R, Stellini E, Roman M, Pinton P, Sivolella S, Zavan B. Nanotechnology to drive stem cell commitment. Nanomedicine (Lond) 2013;8:469-86. [PMID: 23477337 DOI: 10.2217/nnm.13.12] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
6 Hagymási K, Molnár B, Tulassay Z. Stem cell transplantation in the treatment of gastrointestinal diseases. Orvosi Hetilap 2008;149:1449-55. [DOI: 10.1556/oh.2008.28400] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Zhang Y, Wang Q, Yan K, Qi Y, Wang G, Cui Y. Preparation, characterization, and evaluation of genipin crosslinked chitosan/gelatin three-dimensional scaffolds for liver tissue engineering applications: GENIPIN CROSSLINKED SCAFFOLD FOR HEPATOCYTE CULTURE. J Biomed Mater Res 2016;104:1863-70. [DOI: 10.1002/jbm.a.35717] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 7.3] [Reference Citation Analysis]
8 Lysy PA, Campard D, Smets F, Najimi M, Sokal EM. Stem cells for liver tissue repair: Current knowledge and perspectives. World J Gastroenterol 2008; 14(6): 864-875 [PMID: 18240343 DOI: 10.3748/wjg.14.864] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
9 Saito T, Tomita K, Haga H, Okumoto K, Ueno Y. Bone marrow cell-based regenerative therapy for liver cirrhosis. World J Methodol 2013; 3(4): 65-69 [PMID: 25237624 DOI: 10.5662/wjm.v3.i4.65] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ren H, Zhao Q, Cheng T, Lu S, Chen Z, Meng L, Zhu X, Yang S, Xing W, Xiao Y, Ren Q, Chi Y, Gu D, Yang R, Han ZC. No contribution of umbilical cord mesenchymal stromal cells to capillarization and venularization of hepatic sinusoids accompanied by hepatic differentiation in carbon tetrachloride-induced mouse liver fibrosis. Cytotherapy. 2010;12:371-383. [PMID: 20184502 DOI: 10.3109/14653241003596661] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
11 Vainshtein JM, Kabarriti R, Mehta KJ, Roy-Chowdhury J, Guha C. Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2014;89:786-803. [PMID: 24969793 DOI: 10.1016/j.ijrobp.2014.02.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
12 Piscaglia AC, Novi M, Campanale M, Gasbarrini A. Stem cell-based therapy in gastroenterology and hepatology. Minim Invasive Ther Allied Technol. 2008;17:100-118. [PMID: 18465445 DOI: 10.1080/13645700801969980] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
13 Harting MT, Jimenez F, Xue H, Fischer UM, Baumgartner J, Dash PK, Cox CS. Intravenous mesenchymal stem cell therapy for traumatic brain injury. J Neurosurg 2009;110:1189-97. [PMID: 19301973 DOI: 10.3171/2008.9.JNS08158] [Cited by in Crossref: 181] [Cited by in F6Publishing: 100] [Article Influence: 13.9] [Reference Citation Analysis]
14 Burra P, Bizzaro D, Ciccocioppo R, Marra F, Piscaglia AC, Porretti L, Gasbarrini A, Russo FP. Therapeutic application of stem cells in gastroenterology: An up-date. World J Gastroenterol 2011; 17(34): 3870-3880 [PMID: 22025875 DOI: 10.3748/wjg.v17.i34.3870] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
15 Saito T, Okumoto K, Haga H, Nishise Y, Ishii R, Sato C, Watanabe H, Okada A, Ikeda M, Togashi H. Potential therapeutic application of intravenous autologous bone marrow infusion in patients with alcoholic liver cirrhosis. Stem Cells Dev. 2011;20:1503-1510. [PMID: 21417817 DOI: 10.1089/scd.2011.0074] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 4.6] [Reference Citation Analysis]
16 Sasikala M, Surya P, Radhika G, Kumar PP, Rao MS, Mukherjee RM, Rao PN, Reddy DN. Identification of circulating CD90+ CD73+ cells in cirrhosis of liver. World J Stem Cells 2011; 3(7): 63-69 [PMID: 21860671 DOI: 10.4252/wjsc.v3.i7.63] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
17 Piscaglia AC. Stem cells, a two-edged sword: Risks and potentials of regenerative medicine. World J Gastroenterol 2008; 14(27): 4273-4279 [PMID: 18666313 DOI: 10.3748/wjg.14.4273] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
18 Caddeo S, Boffito M, Sartori S. Tissue Engineering Approaches in the Design of Healthy and Pathological In Vitro Tissue Models. Front Bioeng Biotechnol 2017;5:40. [PMID: 28798911 DOI: 10.3389/fbioe.2017.00040] [Cited by in Crossref: 77] [Cited by in F6Publishing: 57] [Article Influence: 15.4] [Reference Citation Analysis]
19 Kazemnejad S, Allameh A, Soleimani M, Gharehbaghian A, Mohammadi Y, Amirizadeh N, Esmaeili S. Functional Hepatocyte-Like Cells Derived from Human Bone Marrow Mesenchymal Stem Cells on a Novel 3-Dimensional Biocompatible Nanofibrous Scaffold. Int J Artif Organs 2008;31:500-7. [DOI: 10.1177/039139880803100605] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
20 El Baz H, Demerdash Z, Kamel M, Hammam O, Abdelhady DS, Mahmoud S, Hassan S, Mahmoud F, Atta S, Riad NM, Gaafar T. Induction of Hepatic Regeneration in an Experimental Model Using Hepatocyte-Differentiated Mesenchymal Stem Cells. Cell Reprogram 2020;22:134-46. [PMID: 32243193 DOI: 10.1089/cell.2019.0076] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Strickland JD, Copple BL. Modulation of macrophage phenotype to treat liver fibrosis-Current approaches and future possibilities. Adv Pharmacol 2021;91:213-28. [PMID: 34099109 DOI: 10.1016/bs.apha.2021.03.001] [Reference Citation Analysis]
22 Zhang Z, Lin H, Shi M, Xu R, Fu J, Lv J, Chen L, Lv S, Li Y, Yu S, Geng H, Jin L, Lau GK, Wang FS. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J Gastroenterol Hepatol. 2012;27 Suppl 2:112-120. [PMID: 22320928 DOI: 10.1111/j.1440-1746.2011.07024.x] [Cited by in Crossref: 197] [Cited by in F6Publishing: 179] [Article Influence: 19.7] [Reference Citation Analysis]
23 Hoppo T, Komori J, Manohar R, Stolz DB, Lagasse E. Rescue of lethal hepatic failure by hepatized lymph nodes in mice. Gastroenterology. 2011;140:656-666.e2. [PMID: 21070777 DOI: 10.1053/j.gastro.2010.11.006] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
24 Piscaglia AC, Campanale M, Gasbarrini A, Gasbarrini G. Stem cell-based therapies for liver diseases: state of the art and new perspectives. Stem Cells Int. 2010;2010:259461. [PMID: 21048845 DOI: 10.4061/2010/259461] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
25 Kwak KA, Cho HJ, Yang JY, Park YS. Current Perspectives Regarding Stem Cell-Based Therapy for Liver Cirrhosis. Can J Gastroenterol Hepatol. 2018;2018:4197857. [PMID: 29670867 DOI: 10.1155/2018/4197857] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 7.5] [Reference Citation Analysis]
26 Lorenzini S, Isidori A, Catani L, Gramenzi A, Talarico S, Bonifazi F, Giudice V, Conte R, Baccarani M, Bernardi M. Stem cell mobilization and collection in patients with liver cirrhosis. Aliment Pharmacol Ther. 2008;27:932-939. [PMID: 18315586 DOI: 10.1111/j.1365-2036.2008.03670.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 2.9] [Reference Citation Analysis]
27 Kazemnejad S, Allameh A, Soleimani M, Gharehbaghian A, Mohammadi Y, Amirizadeh N, Jazayery M. Biochemical and molecular characterization of hepatocyte-like cells derived from human bone marrow mesenchymal stem cells on a novel three-dimensional biocompatible nanofibrous scaffold. J Gastroenterol Hepatol. 2009;24:278-287. [PMID: 18752558 DOI: 10.1111/j.1440-1746.2008.05530.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 84] [Article Influence: 6.6] [Reference Citation Analysis]
28 Han Y, Yan L, Han G, Zhou X, Hong L, Yin Z, Zhang X, Wang S, Wang J, Sun A. Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte-colony-stimulating factor mobilization therapy. Cytotherapy. 2008;10:390-396. [PMID: 18574771 DOI: 10.1080/14653240802129901] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
29 Singare S, Zhong SY, Sun ZZ. A Method to Fabricate Liver Tissue Engineering Scaffold. JBBTE 2011;11:73-80. [DOI: 10.4028/www.scientific.net/jbbte.11.73] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]